Process for preparing orally administered dabigatran formulations

Details for Australian Patent Application No. 2009228795 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Friedl, Thomas; Landerer, Sabine

Agent Spruson & Ferguson

Pub. Number AU-A-2009228795

PCT Pub. Number WO2009/118322

Priority 08153667.4 28.03.08 EP

Filing date 24 March 2009

Wipo publication date 1 October 2009

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/10 (2006.01) Medicinal preparations characterised by special physical form - Dispersions

A61K 9/50 (2006.01) Medicinal preparations characterised by special physical form - Microcapsules

A61K 31/4439 (2006.01)

Event Publications

29 July 2010 PCT application entered the National Phase

  PCT publication WO2009/118322 Priority application(s): WO2009/118322

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009228797-5imidazoquinolines and pyrimidine derivatives as potent modulators of VEGF-driven angiogenic processes

2009228785-Dicyclanil formulation